Statute Details
- Title: Health Products (Medical Devices) Regulations 2010
- Act Code: HPA2007-S436-2010
- Type: Subsidiary legislation (SL)
- Enacting Act (context): Made under the Health Products Act (HPA)
- Status: Current version (as at 27 Mar 2026)
- Primary subject: Regulation of manufacture, import, supply, presentation, advertisement, registration, and post-market obligations for medical devices
- Commencement: Not specified in the provided extract
- Key provisions (from extract): s 2 (definitions); Part IA (licensing for manufacture/import); Part III (supply and exceptions); Part IV–V (presentation/advertising controls); Part VI (registration); Part VIII (duties, records, reporting, enforcement)
- Schedules: Second Schedule (diseases/conditions for advertising restriction); Third Schedule (assignment into classes); Fifth Schedule (implantable medical devices); other schedules repealed/deleted
- Related legislation (as provided): Dental Registration Act 1999; Health Products Act; Healthcare Services Act 2020; Human Biomedical Research Act 2015
What Is This Legislation About?
The Health Products (Medical Devices) Regulations 2010 (“MD Regulations”) form the core regulatory framework for medical devices in Singapore. In plain terms, they set out the rules for how medical devices may be manufactured, imported, supplied, advertised, and registered—so that devices placed on the market meet minimum standards of safety, quality, and performance.
The Regulations operate alongside the Health Products Act and other sectoral laws. They create a licensing and registration regime that distinguishes between different categories of devices (including by risk class), different actors (manufacturers, importers, wholesalers, suppliers, registrants), and different contexts of use (routine clinical use, clinical research, emergency use, and certain limited exceptions).
Practically, the MD Regulations are designed to control the “life cycle” of a medical device: before market entry (licensing, registration, classification), at the point of supply (requirements for particular classes and restricted-use devices), and after market entry (duties to maintain records, report defects/adverse effects, and notify recalls or field safety corrective actions).
What Are the Key Provisions?
1) Definitions and licensing foundations (Part I and Part IA). The Regulations begin with general definitions (s 2), which are critical because many obligations depend on whether something is a “medical device”, and on how it is classified. Part IA then introduces licensing requirements for manufacturers and importers: ss 2A and 2B set out requirements for the issue of a manufacturer’s licence and an importer’s licence, respectively. These licensing provisions are the gateway for legitimate market participation by entities that manufacture or import medical devices for supply in Singapore.
2) Manufacture and import without a licence—limited pathways (Part II). The Regulations recognise that not all activity requires a full licence. Part II provides circumstances where manufacture or import may occur without a licence, but only within defined boundaries. For example, ss 3 and related provisions cover manufacture of medical devices, including special categories such as manufacture for clinical research (s 3A), laboratory-developed tests (s 3B), and certain charitable purposes (s 3C). There are also provisions dealing with specified dental medical devices (s 3D) and manufacture by secondary assembly (s 4).
On the import side, the Regulations include targeted exceptions and pathways: import for personal use (s 4A), import of medical devices licensed under the Radiation Protection Act (s 4B), and import for clinical research (s 4C). These provisions are important for practitioners advising on cross-border supply, research collaborations, and limited personal or institutional use.
3) Supply controls and exceptions for unregistered devices (Part III). Part III is central to day-to-day compliance. It addresses wholesale supply (Division 1), including requirements for a wholesaler’s licence (s 4D) and rules for wholesaling self-manufactured devices (s 5) and certain special categories (ss 5A and 5B). It also addresses “unregistered medical devices” (Division 2), which is where many compliance disputes arise: the Regulations generally require registration for devices intended for supply, but they provide exceptions.
Division 2 includes exceptions for custom-made devices (s 6), devices after maintenance or repair (s 7), devices for patients’ use (s 8), and export or re-export (s 9). There are also exceptions for non-clinical use (s 10) and clinical research (s 10A), as well as a specific exception for Class A medical devices (s 10B). The Regulations further include “phased implementation” exceptions (s 11) and additional exceptions (Division 2A), such as import by a licensed manufacturer without an importer’s licence (s 11A) and wholesale to ships or aircraft by a licensed importer without a wholesaler’s licence (s 11B). There is also a provision for previously registered medical devices (s 11C).
4) Requirements for supply of particular device types (Division 3). Division 3 sets out requirements for supply, including supply of Class A medical devices (s 12) and supply restrictions for devices labelled for “professional use only” (s 13), “trained user only” (s 13B), and devices for clinical research (s 13A). These provisions reflect a risk-based approach: the higher the risk and the more specialised the use, the more tightly the Regulations control who may receive and use the device and under what conditions.
5) Emergency medical devices (Part IIIA). Part IIIA provides an exception framework for emergency medical devices (s 13C). This is a practical necessity: in urgent situations, the regulatory system must allow timely access while still imposing safeguards. For legal advisers, the key is to confirm that the device and circumstances fall within the emergency exception and that any required conditions are met.
6) Presentation and advertising restrictions (Parts IV and V). The Regulations regulate how medical devices are presented and advertised. Part IV includes rules on trade descriptions (s 14), information to be provided with medical devices (s 15), general labelling provisions (s 16), and substantiation requirements for claims of uniqueness and prominence (s 17). If trade descriptions are contravened, corrective measures may be required (s 18).
Part V similarly governs advertising: s 19 requires compliance for advertisements of medical devices, while ss 20 and 21 impose substantiation and special rules for “professional use only” devices. Importantly, s 22 restricts advertisements promoting medical devices for specified diseases and conditions. This is reinforced by the Second Schedule, which lists the diseases and conditions relevant to the advertising restriction. The Authority also has powers to require copies of advertisements (s 23), which is a significant enforcement tool.
7) Registration of medical devices (Part VI). Part VI establishes the registration regime. It includes assignment of devices into classes (s 24), requirements for registration (s 25), and the evaluation process (s 26). There is also a provision for cancellation of registration for non-payment of a retention fee within a prescribed time (s 26A). Practitioners should note the procedural and timing aspects: registration is not merely a one-off approval; it can be cancelled if fees are not paid, which affects ongoing marketability.
Section 27 addresses disclosure of information on applications for registration. This matters for transparency and for managing confidential commercial information during the application process.
8) Post-market duties, records, and reporting (Part VIII). Part VIII is where compliance becomes operational and enforcement-heavy. It imposes duties on licensees, suppliers, registrants, and other responsible parties. Key duties include compliance with enforcement orders (s 31), compliance with licence or registration conditions (s 32), and specific duties for manufacturers (s 33), importers (s 34), and wholesalers (s 35).
There are also duties relating to unregistered Class A medical devices (s 35A), ensuring compliance with safety and performance requirements (s 36), and duties of sponsors in relevant contexts (s 36A). The Regulations include an offence provision for contravention of duties (s 37), underscoring that failures are not merely administrative.
Record-keeping and reporting obligations are extensive: duties to maintain records of manufacture (s 38), supply (s 39), and clinical research-related receipt/supply and use/disposal (ss 39A and 39B). For implantable medical devices, qualified practitioners must maintain records (s 40). There are also duties to maintain records of complaints (s 41), report defects and adverse effects (s 42), report information adversely affecting quality/safety/efficacy (s 43), and notify the Authority concerning recall (s 44) and field safety corrective actions (ss 46–47). Finally, there are duties to furnish reports on recall (s 45) and to notify changes affecting licences or registered devices (ss 48–49).
How Is This Legislation Structured?
The MD Regulations are structured in sequential Parts that mirror the regulatory life cycle of medical devices:
Part I (Preliminary) contains citation/commencement and definitions (ss 1–2). Part IA introduces licensing requirements for manufacturers and importers (ss 2A–2B). Part II provides controlled circumstances for manufacture and import without a licence (ss 3–4C). Part III governs supply, including wholesale licensing (Division 1), exceptions for unregistered devices (Division 2 and Division 2A), and supply requirements for specific categories (Division 3). Part IIIA addresses emergency medical devices (s 13C). Parts IV and V regulate presentation and advertising, including labelling/trade descriptions and substantiation requirements. Part VI sets out registration and evaluation. Part VII contains certificate provisions, with some sections deleted in the extract. Part VIII imposes duties, record-keeping, and reporting obligations. Part X includes miscellaneous provisions such as notices to the Authority, confidentiality, revocation, and savings/transitional provisions.
Who Does This Legislation Apply To?
The Regulations apply to a wide range of persons and entities involved in medical devices in Singapore, including manufacturers, importers, wholesalers, suppliers, registrants, and—depending on the device type—qualified practitioners involved with implantable devices. The obligations vary depending on whether a party holds a licence, whether the device is registered, and whether the device is supplied for clinical use, clinical research, emergency use, or other limited purposes.
In addition, the Regulations apply to advertising and presentation activities by businesses and professionals who market medical devices. Because Part IV and Part V impose substantiation and restriction rules, marketing teams and regulatory affairs counsel must ensure that claims, labelling, and promotional materials comply with the statutory requirements and relevant schedules.
Why Is This Legislation Important?
The MD Regulations are significant because they operationalise Singapore’s medical device regulatory controls under the Health Products framework. For practitioners, the most important practical takeaway is that compliance is not limited to obtaining approvals: the Regulations impose ongoing duties, including record-keeping and mandatory reporting of defects, adverse effects, recalls, and field safety corrective actions.
From an enforcement perspective, the Regulations provide the Authority with strong oversight tools. For example, the power to require copies of advertisements (s 23) and the offence for contravention of duties (s 37) mean that non-compliance can lead to regulatory action and potential criminal liability. The cancellation mechanism for non-payment of retention fees (s 26A) also creates a commercial risk: even a previously registered device can become non-compliant if administrative obligations are missed.
For legal advisers, the Regulations also require careful classification and scoping analysis. Whether a device is Class A, “professional use only”, “trained user only”, intended for clinical research, or falls within an exception (custom-made, repair/maintenance, emergency, export) can determine whether licensing/registration is required and what supply and labelling restrictions apply. This makes the Regulations highly relevant to regulatory strategy, contract drafting (e.g., allocation of responsibilities for reporting and record-keeping), and dispute management in supply chains.
Related Legislation
- Health Products Act (Singapore) (enabling legislation for the MD Regulations)
- Healthcare Services Act 2020
- Human Biomedical Research Act 2015
- Dental Registration Act 1999
Source Documents
This article provides an overview of the Health Products (Medical Devices) Regulations 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.